XOMA Royalty (XOMA) Accumulated Expenses (2010 - 2026)

XOMA Royalty's (XOMA) quarterly Accumulated Expenses came in at $3.2 million in Q1 2026, up 162.98% year-on-year from $1.2 million in Q1 2025, and down 67.52% quarter-over-quarter from $9.9 million in Q4 2025.

XOMA Royalty (XOMA) Accumulated Expenses (2010 - 2026) Analysis & Trends

XOMA Royalty has disclosed Accumulated Expenses across 17 years of filings, most recently posting $3.2 million for Q1 2026.

  • Accumulated Expenses for Q1 2026 came in at $3.2 million, up 162.98% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.2 million (up 162.98% YoY), and the FY2025 annual result was $9.9 million, up 71.85% from the prior year.
  • Accumulated Expenses came in at $3.2 million for Q1 2026 at XOMA Royalty, down from $9.9 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $9.9 million in Q4 2025 to a low of $231000.0 in Q1 2022.
  • The 5-year median for Accumulated Expenses is $1.3 million (2024), against an average of $2.7 million.
  • Across the five-year window, Accumulated Expenses sank 81.67% in 2023 and surged 975.14% in 2024, its largest moves.
  • XOMA Royalty's Accumulated Expenses stood at $2.9 million in 2022, then tumbled by 81.67% to $535000.0 in 2023, then soared by 975.14% to $5.8 million in 2024, then surged by 71.85% to $9.9 million in 2025, then plunged by 67.52% to $3.2 million in 2026.
  • The last three Accumulated Expenses figures came in at $3.2 million (Q1 2026), $9.9 million (Q4 2025), and $4.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn -
7 Psyence Biomedical 238.34 Bn 238.33 Bn -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn
9 Abivax 95.45 Bn 95.45 Bn -
10 XOMA Royalty 5.52 Mn -60.56 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 3.21 Mn
Dec 31, 2025 9.89 Mn
Sep 30, 2025 4.13 Mn
Jun 30, 2025 5.41 Mn
Mar 31, 2025 1.22 Mn
Dec 31, 2024 5.75 Mn
Sep 30, 2024 1.17 Mn
Jun 30, 2024 4.87 Mn
Mar 31, 2024 1.30 Mn
Dec 31, 2023 535,000.00
Sep 30, 2023 902,000.00
Jun 30, 2023 1.93 Mn
Mar 31, 2023 304,000.00
Dec 31, 2022 2.92 Mn
Sep 30, 2022 1.21 Mn
Jun 30, 2022 1.03 Mn
Mar 31, 2022 231,000.00
Dec 31, 2021 525,000.00
Sep 30, 2021 1.33 Mn
Jun 30, 2021 1.06 Mn